| ELDN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ELDN shares outstanding history going back to 11/13/2020:
Also see: ELDN Market Cap History ELDN YTD Return |
ELDN Shares Outstanding History — Eledon Pharmaceuticals Share Count Over Time
As of 5/7/2026 Eledon Pharmaceuticals has 77.19 million ELDN shares outstanding. Investors often track the ELDN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ELDN share count trends over time, with 23 historical shares outstanding datapoints presented, dating back to 11/13/2020.
| ELDN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||
ELDN Historical Shares Outstanding: +107.04% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||
| ELDN Stock Price Chart |
| About Eledon Pharmaceuticals Inc |
| Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is developing immune-modulating therapies for the management and treatment of life-threatening conditions. Co.'s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target within the costimulatory CD40/CD40L cellular pathway. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. We show 23 historical shares outstanding datapoints in our coverage of ELDN's shares outstanding history. Understanding the changing numbers of ELDN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELDN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELDN by allowing them to research ELDN shares outstanding history as well as any other stock in our coverage universe. |
| ELDN Current Stock Quote |
Quotes delayed 20 minutes  Free ELDN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ELDN Share Performance |
| Shares Outstanding Peers |
| Eledon Pharmaceuticals (ELDN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ELEV Shares Outstanding History ELGX Shares Outstanding History ELOX Shares Outstanding History ELTX Shares Outstanding History ELUT Shares Outstanding History ELVN Shares Outstanding History ELYM Shares Outstanding History EMBC Shares Outstanding History EMMA Shares Outstanding History ENDP Shares Outstanding History More Healthcare companies » |
ELDN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
